Mirabegron - Overactive bladder (adults)
You are here : Home > Formulary Search > Mirabegron - Overactive bladder (adults)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green (see narrative)
Formulations :
- Not Specified
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
Guidelines (Local)
NICE Technology Appraisal
Patient resource
PAD Profile
ChemicalSubstance :
Mirabegron
Indication :
Overactive bladder (adults)
Group Name :
Keywords :
OAB, urge incontinence, urinary incontinence, urinary frequency, LUTS, over-active bladder, urinary urgency
Brand Names Include :
Betmiga
Important Information :
Solifenacin is 1st line.
Mirabegron for use when antimuscarinics are contraindicated, patients with CNS adverse effects or patients requiring a more potent treatment.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
5
Committee Recommendations (2)
The APC supports patients in trialling a treatment break of their overactive bladder medicines.
A "Leaflet for trial of stopping mirabegron" can be found in the documents section.
Solifenacin is the 1st line treatment option.
Mirabegron is reserved for patients:
- in whom an antimuscarininc is contraindicated
- requiring (and can tolerate) a more potent treatment
- 3rd line where experiencing CNS adverse effects (confusion, drowsiness, hallucinations)
See Selection Tool for locally agreed OAB treament options
Other Indications
Below are listed other indications that Mirabegron is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Overactive bladder (adults).